🧠 Trade Thesis: DGX-Strong Vitals, Minor Fever

Quest Diagnostics $DGX ( ▲ 1.96% ) is a core player in U.S. diagnostic services. A $0.10 guidance cut in Q1 2025 spooked some folks-but we see a solid, scalable business with long-term tailwinds and an undervalued chart.

💡 Why We're Long DGX

• Expanding Market Share in a fragmented diagnostics space

• Defensive Sector: Stable demand regardless of economic cycles

• Strong KPIs despite a minor Q1 weather-related hiccup

• Healthy Margins and solid cash flow

• Low EV/Sales vs. historical valuation norms

• Dividend Growth (recently boosted 6.7%) = management confidence

📊 Fundamentals Snapshot

• Q1 Revenue Up 12% YoY, with ~2.5% organic growth

• High EBITDA Margins signal pricing power and efficiency

• Solid Balance Sheet + dividend = long-term strength

• Healthcare Tailwinds: Aging population, preventative care, and precision medicine are secular growth trends

DGX isn't a flashy name. It's just a profitable, well-run company in a sector that rarely goes out of style.

⚖️ Valuation: Still Undervalued

• Low EV/Sales = market is mispricing the upside

• Stock insights tools show DGX trading at a 20–26% discount

• Analyst targets lean bullish (some $190+), and with momentum, a re-rating is possible

📈 Technicals: Building a Base for Breakout

• Current Price (May 12, 2025): $173.44

• Above 20-week and 50-week SMAs

• Golden Cross on Weekly Chart (20-week SMA > 50-week) = bullish momentum forming

• Long Term Support: $163.00

• Resistance: $180.00

• Price Targets:

  • 🎯 First Target: $190

  • 🚀 Stretch Target: $220–230

💥 Trade of the Week: Buy Stock + Sell Puts

Here’s how we’re playing the upside:

✅ Buy the Stock

• Entry: $173.44

• Upside: Unlimited

• Risk: Downside managed via optional stop-loss (suggested below $150 or by trailing)

💸 Sell Puts for Premium (Cash-Secured

• Sell June $165 Put for ~$1.75

• If DGX stays above $165, you keep the premium.

• If it drops, you’re assigned at a net price of $163.25-a level we’re happy to own at.

🚀 Catalysts We’re Watching

1. Earnings Beats + upward guidance revisions

2. New diagnostic products or strategic partnerships

3. Reimbursement/Policy Wins boosting sector outlook

4. Bullish Analyst Revisions

5. M&A headlines or new acquisitions

6. Technical breakout above $190

🛑 Risk Management Tip

🧠 Final Thoughts

DGX isn’t exciting-but boring can be beautiful. While some traders chase high-volatility names, we’re after high-probability setups.

Quest Diagnostics offers a steady path to upside-with the balance sheet, margins, and macro trends to back it.

When the market misprices quality, we step in.

💸 Action Plan:

• Buy DGX around $173

• Sell the June $165 Puts

• Rinse and repeat monthly with 30 delta puts while riding it up

Want trade ideas like this every week-plus strategic options plays and institutional-grade setups?

👉 Join the Paid Resilient Trader Newsletter

Stay Liquid,
- The Resilient Trader